NCT06146101Phase 2, phase 3Completed

RePOSA-Revealing the Efficacy of IHL-42X Use in Patients With OSA

Study sponsor: Incannex Healthcare Ltd

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2025-05-20Actual
Enrollment · participants121Actual
Source updated2026-07-27Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 5 fields changed

Participant count type changed

Before: Estimated. After: Actual.

Enrollment · participant count changed

Before: 560 participants (planned). After: 121 participants (actual).

Completion date type changed

Before: Estimated. After: Actual.

Primary completion date changed

Before: Dec 2026. After: 20 May 2025.

Recruitment status changed

Before: Active not recruiting. After: Completed.

Check registry source

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview